A prospective multicenter MRI screening study in Dutch has demonstrated that the supplemental screening MRI would benefit the early cancer detection and the prognosis in women with BRCA1/2 mutations after an over 9-year follow-up (32). The gene discussed is BRCA1; the disease is cancer.